CompletedNot Applicable

Multidisciplinary Support Program in Chronic Hepatitis C

Spain447 participantsStarted 2003-01

Plain-language summary

Adherence to antiviral treatment in chronic hepatitis C (CHC) is an important factor to achieve sustained virological response (SVR). The aim of our study is to evaluate the efficacy of a multidisciplinary support program (MSP) in adherence to and efficacy of pegylated interferon alfa-2a and ribavirin compared to the conventional approach. We assessed 447 patients with CHC receiving antiviral treatment distributed into 3 groups: control group (recruited 2002-2004, n= 147), MSP-pilot group (recruited 2005-2006, n=131), and MSP-validation group (recruited 2007-2009, n=169).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with chronic hepatitis C eligible to receive antiviral treatment. Exclusion Criteria: * Patients who had undergone previous antiviral treatment, those with human immunodeficiency virus (HIV) or hepatitis B virus (HBV) co-infection, and individuals included in other treatment protocols.

What they're measuring

Adherence to Treatment

Timeframe: 48 months

Trial details

NCT IDNCT01850745

SponsorParc de Salut Mar

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2009-01

Results submitted2017-09-22

View on ClinicalTrials.gov More Hepatitis C, Chronic trials